Back
Adaptive Biotechnologies Stock Price Chart
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
70
ADPT
Adaptive Biotechnologies
Last Price:
$9.03
Seasonality Move:
19.88%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is moderately bullish and ADPT is experiencing selling pressure, which indicates risk of future bearish movement.
Adaptive Biotechnologies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.22 | Sell |
| 20-day SMA: | 8.28 | Buy |
| 50-day SMA: | 7.98 | Buy |
| 200-day SMA: | 6.31 | Buy |
| 8-day EMA: | 9.04 | Sell |
| 20-day EMA: | 8.58 | Buy |
| 50-day EMA: | 8.11 | Buy |
| 200-day EMA: | 6.69 | Buy |
Adaptive Biotechnologies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.42 | Buy |
| Relative Strength Index (14 RSI): | 56.19 | Buy |
| Chaikin Money Flow: | -1474478 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.31 - 9.11) | Buy |
| Bollinger Bands (100): | (6.83 - 8.49) | Buy |
Adaptive Biotechnologies Technical Analysis
| May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Adaptive Biotechnologies Stock
Is Adaptive Biotechnologies Stock a Buy?
-
Adaptive Biotechnologies share price is 9.04 while ADPT 8-day simple moving average is 9.22, which is a Sell signal.
-
The stock price of ADPT is 9.04 while Adaptive Biotechnologies 20-day SMA is 8.28, which makes it a Buy.
-
Adaptive Biotechnologies 50-day simple moving average is 7.98 while ADPT share price is 9.04, making it a Buy technically.
-
ADPT stock price is 9.04 and Adaptive Biotechnologies 200-day simple moving average is 6.31, creating a Buy signal.
ADPT Technical Analysis vs Fundamental Analysis
Buy
70
Adaptive Biotechnologies (ADPT)
is a Buy
Is Adaptive Biotechnologies a Buy or a Sell?
-
Adaptive Biotechnologies stock is rated a BuyThe current Adaptive Biotechnologies [ADPT] share price is $9.04. The Score for ADPT is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
Adaptive Biotechnologies Stock Info
Market Cap:
1.4B
Price in USD:
9.04
Share Volume:
1.7M
Adaptive Biotechnologies 52-Week Range
52-Week High:
10.28
52-Week Low:
2.99
Buy
70
Adaptive Biotechnologies (ADPT)
is a Buy
Adaptive Biotechnologies Share Price Forecast
-
What is the Adaptive Biotechnologies stock price today?The Adaptive Biotechnologies stock price is 9.04 USD today.
-
Will ADPT stock go up or go down?Adaptive Biotechnologies> share price is forecast to RISE/FALL based on technical indicators
-
Is Adaptive Biotechnologies overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptive Biotechnologies is not overvalued.
Is Adaptive Biotechnologies Stock a Buy?
-
Adaptive Biotechnologies share price is 9.04 while ADPT 8-day exponential moving average is 9.04, which is a Sell signal.
-
The stock price of ADPT is 9.04 while Adaptive Biotechnologies 20-day EMA is 8.58, which makes it a Buy.
-
Adaptive Biotechnologies 50-day exponential moving average is 8.11 while ADPT share price is 9.04, making it a Buy technically.
-
ADPT stock price is 9.04 and Adaptive Biotechnologies 200-day simple moving average is 6.69, creating a Buy signal.
Fundamental Analysis of Adaptive Biotechnologies
Is Adaptive Biotechnologies a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.27 per share, and an increase next year of $0.23 per share.
Technical Analysis of Adaptive Biotechnologies
Should I short Adaptive Biotechnologies stock?
-
ADPT Moving Average Covergence Divergence (MACD) indicator is 0.42, suggesting Adaptive Biotechnologies is a Buy
-
Adaptive Biotechnologies Relative Strength Index (RSI) is 56.19, which suggest Adaptive Biotechnologies is overbought
-
The Bollinger Bands (25) for Adaptive Biotechnologies is (7.31 - 9.11), which suggest Adaptive Biotechnologies is a Buy
-
The Bollinger Bands (100) for Adaptive Biotechnologies is (6.83 - 8.49), which suggest Adaptive Biotechnologies is a Buy
* Adaptive Biotechnologies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.